Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$34.4M Sell
1,058,608
-61,209
-5% -$1.93M 0.25% 46
2016
Q4
$34.5M Buy
1,119,817
+148,725
+15% +$4.54M 0.27% 43
2016
Q3
$31.2M Buy
971,092
+28,898
+3% +$966K 0.26% 44
2016
Q2
$31.5M Buy
942,194
+30,315
+3% +$968K 0.29% 41
2016
Q1
$25.6M Buy
911,879
+213,197
+31% +$6.09M 0.25% 46
2015
Q4
$21.4M Buy
698,682
+17,473
+3% +$550K 0.22% 53
2015
Q3
$20.3M Buy
681,209
+10,061
+1% +$323K 0.22% 50
2015
Q2
$21.4M Sell
671,148
-70,474
-10% -$2.3M 0.24% 48
2015
Q1
$24.5M Buy
741,622
+26,469
+4% +$842K 0.28% 47
2014
Q4
$21.1M Sell
715,153
-23,062
-3% -$661K 0.26% 49
2014
Q3
$20.7M Buy
738,215
+5,712
+0.8% +$160K 0.28% 49
2014
Q2
$20.6M Buy
732,503
+2,767
+0.4% +$78.9K 0.3% 47
2014
Q1
$22.2M Buy
729,736
+35,818
+5% +$1.07M 0.35% 45
2013
Q4
$20.2M Buy
693,918
+10,745
+2% +$313K 0.33% 45
2013
Q3
$18.6M Buy
683,173
+32,181
+5% +$876K 0.35% 42
2013
Q2
$17.3M Buy
+650,992
New +$18M 0.36% 39

Other funds holding PFE

TIAA CREF Trust's PFE Position: Q1 2017 in Review

TIAA CREF Trust reduced its Pfizer (PFE) stake by 5.5% in Q1 2017, selling an estimated $1.93M and leaving 1,058,608 shares worth $34.4M. The position accounts for 0.25% of the portfolio, ranked #46.

TIAA CREF Trust first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. The position peaked at $34.5M in Q4 2016. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • TIAA CREF Trust held 1,058,608 shares of Pfizer worth $34.4M as of Q1 2017.
  • TIAA CREF Trust sold 61,209 Pfizer shares in Q1 2017, an estimated $1.93M.
  • Pfizer made up 0.25% of TIAA CREF Trust's portfolio in Q1 2017, its #46 holding.
  • TIAA CREF Trust first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
  • TIAA CREF Trust's Pfizer position peaked at $34.5M in Q4 2016.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.